<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03860935</url>
  </required_header>
  <id_info>
    <org_study_id>AG10-301</org_study_id>
    <secondary_id>2018-004280-32</secondary_id>
    <nct_id>NCT03860935</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy</brief_title>
  <acronym>ATTRIBUTE-CM</acronym>
  <official_title>A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects With Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTRIBUTE-CM Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eidos Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eidos Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase 3 efficacy and safety study to evaluate AG10 800 mg compared to placebo in subjects
      with symptomatic Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed condition believed to
      affect more than 400,000 people worldwide. In ATTR-CM, the accumulation of transthyretin
      (TTR) amyloid results in thickening and stiffening of the heart, which often leads to heart
      failure or even death.

      There are two forms of ATTR-CM:

        -  Wild Type* This form of the condition primarily develops in older individuals who do not
           carry gene mutations

        -  Hereditary* This form of the condition comes from gene mutations passed down in families

      In this study we are researching the investigational drug AG10 800mg administered orally
      twice a day. Through the study, we want to evaluate the efficacy and safety of AG10 in
      patients with ATTR-CM versus placebo

      This is a 30 month, placebo-controlled study. This means that, during the 30 month study,
      investigators conducting the research and study participants will not know whether the study
      participant is receiving AG10 or placebo

      The primary outcomes of the study are:

        1. The impact of AG10 versus placebo on the 6 minute walk test after 12 months of treatment

        2. The impact of AG10 versus placebo on the frequencies of deaths and
           cardiovascular-related hospitalizations after 30 months of treatment

      At the end of 30 months, participants may be eligible to receive investigational AG10, and
      there is no placebo. This is called an &quot;open label extension.&quot; This part of the study may
      help us better understand the safety related to taking AG10 over a longer period of time
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 19, 2019</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 Minute Walk Test (6MWT) at Month 12</measure>
    <time_frame>at Month 12</time_frame>
    <description>Change from baseline to Month 12 of treatment in the total distance walked in 6 minutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total number of deaths due to all-cause and frequency of cardiovascular-related hospitalization</measure>
    <time_frame>30 months</time_frame>
    <description>A hierarchical combination of all-cause mortality (total number of deaths due to all-cause) and frequency of cardiovascular-related hospitalization over a 30-month period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kansas City Cardiomyopathy Questionnaire (KCCQ) at Month 12</measure>
    <time_frame>at Month 12</time_frame>
    <description>Change from Baseline to Month 12 as measured in the Kansas City Cardiomyopathy Questionnaire Overall Summary score (OS). The KCCQ is a 23-item questionnaire developed to measure health status and health-related quality of life in subjects with heart failure. Items include heart failure symptoms, impact on physical and social functions, and how their heart failure impacts their quality of life (QoL). An Overall Summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, scores are transformed to a range of 0-100 using the formula, 100*[(mean of questions actually answered) - 1]/4, in which higher scores reflect better health status. The Overall Summary score is the mean of the domains scores, range from 0 to 100, in which higher scores reflect better health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walk Test (6MWT) at Month 30</measure>
    <time_frame>at Month 30</time_frame>
    <description>Change from baseline to Month 30 of treatment in the total distance walked in 6 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kansas City Cardiomyopathy Questionnaire (KCCQ) at Month 30</measure>
    <time_frame>at Month 30</time_frame>
    <description>Change from Baseline to Month 30 as measured in the Kansas City Cardiomyopathy Questionnaire Overall Summary score (OS). The KCCQ is a 23-item questionnaire developed to measure health status and health-related quality of life in subjects with heart failure. Items include heart failure symptoms, impact on physical and social functions, and how their heart failure impacts their quality of life (QoL). An Overall Summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, scores are transformed to a range of 0-100 using the formula, 100*[(mean of questions actually answered) - 1]/4, in which higher scores reflect better health status. The Overall Summary score is the mean of the domains scores, range from 0 to 100, in which higher scores reflect better health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of treatment-emergent events</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment of incidence of treatment- emergent serious adverse events (SAEs) and adverse events (AEs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of treatment-emergent events</measure>
    <time_frame>30 months</time_frame>
    <description>Assessment of incidence of treatment- emergent serious adverse events (SAEs) and adverse events (AEs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AG10 Pharmacodynamic Assessments of TTR stabilization by Fluorescent Probe Exclusion Assay at Day 28</measure>
    <time_frame>at Day 28</time_frame>
    <description>AG10 binding to and/or stabilization of TTR will be evaluated by established ex vivo assays: Fluorescent Probe Exclusion Assay (FPE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AG10 Pharmacodynamic Assessments of TTR stabilization by Fluorescent Probe Exclusion Assay through Month 30</measure>
    <time_frame>30 months</time_frame>
    <description>AG10 binding to and/or stabilization of TTR will be evaluated by established ex vivo assays: Fluorescent Probe Exclusion Assay (FPE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AG10 Pharmacodynamic Assessments of TTR stabilization by Western Blot at Day 28</measure>
    <time_frame>at Day 28</time_frame>
    <description>AG10 binding to and/or stabilization of TTR will be evaluated by established ex vivo assays: Immunoblotting (Western Blot)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AG10 Pharmacodynamic Assessments of TTR stabilization by Western Blot through Month 30</measure>
    <time_frame>30 months</time_frame>
    <description>AG10 binding to and/or stabilization of TTR will be evaluated by established ex vivo assays: Immunoblotting (Western Blot)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>30 months</time_frame>
    <description>Total number of deaths in the study due to all-cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of cardiovascular-related hospitalization</measure>
    <time_frame>30 months</time_frame>
    <description>Number of times a subject is hospitalized for cardiovascular-related causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular-related mortality</measure>
    <time_frame>30 months</time_frame>
    <description>Total number of deaths adjudicated as being related to cardiovascular causes</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Effect of AG10 on levels of biomarkers of myocardial wall stress and microvascular ischemia</measure>
    <time_frame>30 months</time_frame>
    <description>Changes in levels of N-terminal pro-Brain-type Natriuretic Peptide (NT-proBNP) and Troponin I (TnI)</description>
  </other_outcome>
  <other_outcome>
    <measure>AG10 Pharmacokinetic Assessments</measure>
    <time_frame>30 months</time_frame>
    <description>Pharmacokinetic measures of AG10 and its predominant metabolite after oral administration BID in subjects with symptomatic ATTR-CM for steady state (every 3 months), in a subgroup of subjects</description>
  </other_outcome>
  <other_outcome>
    <measure>Effect of AG10 on health-related quality of life questionnaire EuroQol EQ-5D-5L</measure>
    <time_frame>30 months</time_frame>
    <description>Change from Baseline to Month 30 in the EQ-5D-5L score. EQ-5D-5L consists of 2 parts: EQ-5D descriptive system and EQ visual analogue scale (EQ VAS). EQ-5D comprises five dimensions: mobility, self-care, usual activities, pain or discomfort and anxiety or depression. Each dimension in EQ-5D-5L has five response levels of function: no problem (Level 1); slight problem (Level 2); moderate problem (Level 3); severe problem (Level 4); and extreme problem (Level 5). The subject is asked to indicate his health state by ticking the box next to the most appropriate statement in each of the five dimensions. The digits for the five dimensions can be combined into a 5-digit number, the utility score, that describes the subject's health state. A lower value indicates better perceived health state. On EQ VAS, the subject circles a single rating of self-perceived health on a 0 to 100 mm scale representing &quot;the worst imaginable health state&quot; and &quot;the best imaginable health state&quot;, respectively.</description>
  </other_outcome>
  <other_outcome>
    <measure>AG10 activity across TTR mutations</measure>
    <time_frame>At Baseline</time_frame>
    <description>AG10 binding to or stabilization across a panel of TTR mutations by additional assays</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">510</enrollment>
  <condition>Amyloidosis</condition>
  <condition>Amyloid Cardiomyopathy</condition>
  <condition>Transthyretin Amyloidosis</condition>
  <condition>Cardiomyopathies</condition>
  <condition>Heart Diseases</condition>
  <arm_group>
    <arm_group_label>AG10 800 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive AG10 800 mg twice daily. 6 Minute Walk Test (6MWT) primary outcome will be assessed at the end of 12 months, followed by all-cause mortality and cardiovascular-related hospitalization assessed at the end of 30 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will receive placebo to match twice daily. 6 Minute Walk Test (6MWT) primary outcome will be assessed at the end of 12 months, followed by all-cause mortality and cardiovascular-related hospitalization assessed at the end of 30 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AG10</intervention_name>
    <description>TTR stabilizer administered orally twice daily (BID)</description>
    <arm_group_label>AG10 800 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>Non-active control administered orally twice daily (BID)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have an established diagnosis of ATTR-CM with either wild-type TTR or variant TTR
             genotype

          -  Have a history of heart failure evidenced by at least one prior hospitalization for
             heart failure or clinical evidence of heart failure without prior heart failure
             hospitalization manifested by signs or symptoms of volume overload or elevated
             intracardiac pressures or heart failure symptoms that required or require ongoing
             treatment with a diuretic.

          -  New York Heart Association (NYHA) Class I-III symptoms due to ATTR cardiomyopathy.

          -  On stable doses of cardiovascular medical therapy

          -  Completed ≥150 m on the 6MWT on 2 tests prior to randomization

          -  Biomarkers of myocardial wall stress, NT-proBNP level ≥300 pg/mL

          -  Have left ventricular wall (interventricular septum or left ventricular posterior
             wall) thickness ≥12 mm

        Exclusion Criteria:

          -  Had acute myocardial infarction, acute coronary syndrome or coronary
             revascularization, or experienced stroke or transient ischemic attack within 90 days
             prior to screening

          -  Has hemodynamic instability

          -  Likely to undergo heart transplantation within a year of screening

          -  Confirmed diagnosis of primary (light chain) amyloidosis

          -  Biomarkers of myocardial wall stress, NT-proBNP level ≥8500 pg/mL at screening

          -  Measure of kidney function, eGFR by MDRD formula &lt;15 mL/min/1.73 m2

          -  Current treatment with marketed drug products and other investigational agents for the
             treatment of ATTR-CM

          -  Current treatment with calcium channel blockers with conduction system effects (e.g.
             verapamil, diltiazem). The use of dihydropyridine calcium channel blockers is allowed.
             The use of digitalis will only be allowed if required for management of atrial
             fibrillation with rapid ventricular response
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vincent Knobel</last_name>
    <phone>4158871471</phone>
    <email>clinicaltrials@eidostx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Wilson</last_name>
      <email>Vanessa.Wilson@csmns.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital - Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kylie Boynton</last_name>
      <email>kylie.boynton@cuanschutz.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06473</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Hinchion</last_name>
      <email>nancy.hinchion@ynhh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hellina Birru</last_name>
      <email>hellina.t.birru@medstar.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Miami - Sylvester Comprehensive Cancer Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Falcon</last_name>
      <email>oxf121@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory Heart and Vascular Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Walker</last_name>
      <email>brandon.ariel.walker@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Medina</last_name>
      <email>frank.medina@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey Silverstein</last_name>
      <email>tsilvers@medicine.bsd.uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Pierchala</last_name>
      <email>LPierchala@northshore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janna Hilligoss</last_name>
      <email>jhilligo@iupui.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Health System</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Boston University School of Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Lazzari</last_name>
      <email>vlazzari@bu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barbara Ann Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane Houde</last_name>
      <email>houdec@karmanos.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanna Miller</last_name>
      <email>miller.susanna@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital - Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Smith</last_name>
      <email>jnsmith@saint-lukes.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Foster</last_name>
      <email>caroline.foster@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nevada Heart and Vascular Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicia Bracken</last_name>
      <email>aliciab@nevadaheart.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Policastro</last_name>
      <email>patricia.policastro@rwjbh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Estefania Hernandez</last_name>
      <email>eshernande@montefiore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York University Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zarina Iskhakova</last_name>
      <email>zarina.iskhakova@nyulangone.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Tlachi</last_name>
      <email>pilar.tlachi@mountsinai.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Helmke</last_name>
      <email>sh2669@cumc.columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laurelton Heart Specialist</name>
      <address>
        <city>Rosedale</city>
        <state>New York</state>
        <zip>11422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anika Tasnim</last_name>
      <email>research@queensheartinstitute.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina - Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyrone Wade</last_name>
      <email>tyrone_wade@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine Arges</last_name>
      <email>kristine.arges@duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Kerchenski</last_name>
      <email>kerchel@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Muhlenkamp</last_name>
      <email>ashley.muhlenkamp@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie Cohen</last_name>
      <email>cohene@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn Presbyterian Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Divito</last_name>
      <email>patricia.divito@uphs.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghana Bohra</last_name>
      <email>meghana.bohra@ahn.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Basch</last_name>
      <email>baschmk@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine Bataille</last_name>
      <email>batalle@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prisma Health - Greenville Memorial Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Miller</last_name>
      <email>leah.miller2@prismahealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Heart - Saint Thomas West Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Carolyn</last_name>
      <email>carolyn.kelly@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Hong</last_name>
      <email>Jennifer.Hong@hsc.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bhruga Shah</last_name>
      <email>bhruga.shah@inova.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Cei</last_name>
      <email>laura.cei@vcuhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic Roanoke Heart Institute</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Davis</last_name>
      <email>kathy.davis@roanokeheart.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington School of Medicine</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fatimah Ranjbaran</last_name>
      <email>franjbaran@cardiology.washington.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Passey</last_name>
      <email>lisa.passey@providence.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tania Lewis</last_name>
      <email>tania.lewis@health.sa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Arnold</last_name>
      <email>liz.arnold@monash.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Hobart</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Grabek</last_name>
      <email>teresa.grabek@ths.tas.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gill Tulloch</last_name>
      <email>gill.tulloch@health.wa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Vincent's Hospital Sydney</name>
      <address>
        <city>Sydney</city>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clare Coates</last_name>
      <email>clare.coates@svha.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Hall</last_name>
      <email>cindy.hall@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg - Campus Sint-Jan</name>
      <address>
        <city>Genk</city>
        <state>Limburg</state>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evi Theunissen</last_name>
      <email>evi.theunissen@zol.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onze-Lieve-Vrouw Ziekenhuis Aalst</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hedwig Batjoens</last_name>
      <email>hedwig.batjoens@olvz-aalst.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veerle Servaes</last_name>
      <email>veerle.servaes@uzleuven.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Cárdio Pulmonar</name>
      <address>
        <city>Salvador</city>
        <state>Bahia</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Queila de Oliveira</last_name>
      <email>cec@cardiopulmonar.com.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de Cardiologia do Rio Grande do Sul</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Poletti</last_name>
      <email>pesquisaclinica@cardiologia.org.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberley Ronak</last_name>
      <email>kronak@ucalgary.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba - St. Boniface</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Janz</last_name>
      <email>wjanz@hsc.mb.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montréal</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Brown</last_name>
      <email>helene.brown@icm-mhi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Anne´s University Hospital</name>
      <address>
        <city>Brno Střed</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Krejci</last_name>
      <email>jan.krejci@fnusa.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>General University Hospital in Prague</name>
      <address>
        <city>Nové Město</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomas Palecek</last_name>
      <email>tomas.palecek@vfn.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milos Kubanek</last_name>
      <email>mikb@ikem.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus Universitetshospital</name>
      <address>
        <city>Aarhus</city>
        <state>Dinamarca</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Leth</last_name>
      <email>marlet@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elaine Gilroy</last_name>
      <email>egilroy@mater.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Vincents University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Maher</last_name>
      <email>j.maher@stmichaels.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah University Hospital Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galina Levin</last_name>
      <email>lenving@hadassah.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nava Eizenberg</last_name>
      <email>nava.eizenberg@sheba.health.gov.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Donato</name>
      <address>
        <city>Arezzo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Giustini</last_name>
      <email>sara.giustini@uslsudest.toscana.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero - Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katia Baldini</last_name>
      <email>Baldinik@aou-careggi.toscana.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleonora Di Buduo</last_name>
      <email>e.dibuduo@smatteo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi</name>
      <address>
        <city>Rimini</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Mezzena</last_name>
      <email>dina.mezzena@auslromagna.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-Do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Kyung Choi</last_name>
      <email>solinho@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Gyeonggi-Do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han Na Choi</last_name>
      <email>hannana59@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geert Bokhorst</last_name>
      <email>g.bokhorst@umcg.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Vlaardingerbroek</last_name>
      <email>k.vlaardingerbroek@umcutrecht.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Otahuhu</city>
        <state>Auckland</state>
        <zip>1640</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynette Pearce</last_name>
      <email>Lynette.Pearce@mmclintrials.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Waikato</state>
        <zip>3240</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Jaques</last_name>
      <email>sharonj@cardiotrialswaikato.org.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Lisboa Norte EPE- Hospital Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joana Ferreira</last_name>
      <email>joanarferreira@medicina.ulisboa.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto</name>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inês Cardoso</last_name>
      <email>inescardoso.defi@chporto.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clínica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Teresa San Miguel</last_name>
      <email>msanm.2@unav.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paloma Gastelurrutia</last_name>
      <email>pgastelurrutia@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Ramón Jiménez</name>
      <address>
        <city>Huelva</city>
        <zip>21005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Álvaro Gragera</last_name>
      <email>alvaro.gragera.sspa@juntadeandalucia.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Ramón Jiménez</name>
      <address>
        <city>Huelva</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Álvaro Gragera</last_name>
      <email>alvaro.gragera.sspa@juntadeandalucia.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Universidad de Navarra Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mar García Iturralde</last_name>
      <email>mgarciai@unav.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariadna González Segovia</last_name>
      <email>ariadna.segovia@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Son Llàtzer</name>
      <address>
        <city>Palma De Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Melia Mesquida</last_name>
      <email>catalina.melia@hsll.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Seijas Amigo</last_name>
      <email>jose.seijas.amigo@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Mollar</last_name>
      <email>annam.mollar@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>NW3 2PF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Rannigan</last_name>
      <email>lisa.rannigan@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Richmond Pharmacology</name>
      <address>
        <city>London</city>
        <zip>SE1 1YR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Hill</last_name>
      <email>l.hill@richmondpharmacology.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Portugal</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>February 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2019</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amyloidosis</keyword>
  <keyword>ATTR-CM</keyword>
  <keyword>Transthyretin</keyword>
  <keyword>Amyloid</keyword>
  <keyword>TTR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

